The French state says it is taking legal action against under-fire nursing home giant Orpea, and demanding the group repays public money which it alleges was misused. The decision follows the findings of a public inquiry into alleged malpractice.
HBI hears from multiple sources that NHS-focussed UK dental group Rodericks Dental is set to buy UK rival Dental Partners from London-based private equity August Equity.
Swiss investment group Aevis Victoria achieved strong financial results in 2021, thanks in large part to sales of stakes in hospital group Swiss Medical Network and ambulance group Swiss Ambulance Rescue Genève and a return to normality seen in both the healthcare and hospitality sectors.
Could the bubble be bursting for digital scheduling companies as Google nudges its way in with a new booking feature specifically for healthcare? We take a closer look at what Google's latest plans might mean for the industry.
Healthcare Activos has new investors as of today - and big plans for tomorrow and beyond. HBI catches up with its clearly enthused founder and executive chairman Jorge Guarner and CEO Albert Fernandez to find out more about their plans for expansion.
Asia's largest for-profit healthcare group IHH Healthcare has made a buyout offer to Malaysian-based hospital group Ramsay Sime Darby Health Care (RSDHD) of US$1.35bn.
Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.
As China's biggest city Shanghai faces a staggered Covid lockdown, HBI catches up with a Chinese healthcare expert who tells us that premium international operators could be significantly hit.
Infermedica, the Polish health tech start-up, will expand its US investments, thanks to the funding gained in a recent Series B financing round. HBI talks with Miłosz Wiciński, Business Development Executive at Infermedica, to learn more.
Europe, with its often rigorous divides between research institutes and university hospitals, has fallen a long way behind power houses such as MIT/Harvard/Mass General in the generation of applied medical science. So how do you build a successful healthcare science cluster in Europe?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.